ID: ALA5204852

Max Phase: Preclinical

Molecular Formula: C93H144N30O35

Molecular Weight: 2242.35

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)CCC(=O)NCCCOCCOCCOCCCNC(=O)CCC(=O)OC[C@H]1O[C@@H](c2n[nH]nc2C(N)=O)[C@H](O)[C@@H]1O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O

Standard InChI:  InChI=1S/C93H144N30O35/c1-7-44(4)71(91(152)116-57(34-65(96)130)84(145)109-51(15-10-20-104-93(99)100)81(142)120-72(46(6)127)92(153)107-45(5)80(141)110-52(29-43(2)3)82(143)113-56(33-64(95)129)86(147)118-61(40-126)90(151)114-55(32-63(94)128)85(146)115-58(35-69(134)135)87(148)117-59(38-124)78(97)139)119-88(149)54(31-48-37-101-42-106-48)112-83(144)53(30-47-36-105-50-14-9-8-13-49(47)50)111-89(150)60(39-125)108-68(133)17-16-66(131)102-21-11-23-154-25-27-156-28-26-155-24-12-22-103-67(132)18-19-70(136)157-41-62-75(137)76(138)77(158-62)73-74(79(98)140)122-123-121-73/h8-9,13-14,36-37,42-46,51-62,71-72,75-77,105,124-127,137-138H,7,10-12,15-35,38-41H2,1-6H3,(H2,94,128)(H2,95,129)(H2,96,130)(H2,97,139)(H2,98,140)(H,101,106)(H,102,131)(H,103,132)(H,107,153)(H,108,133)(H,109,145)(H,110,141)(H,111,150)(H,112,144)(H,113,143)(H,114,151)(H,115,146)(H,116,152)(H,117,148)(H,118,147)(H,119,149)(H,120,142)(H,134,135)(H4,99,100,104)(H,121,122,123)/t44-,45-,46+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62+,71-,72-,75+,76+,77-/m0/s1

Standard InChI Key:  DMKNQQHBZSWSNN-VLOIVFQTSA-N

Associated Targets(Human)

Huh-7.5 200 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus 23859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Zika virus 1028 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 2242.35Molecular Weight (Monoisotopic): 2241.0410AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Gonzalez S, Brzuska G, Ouarti A, Gallier F, Solarte C, Ferry A, Uziel J, Krol E, Lubin-Germain N..  (2022)  Anti-HCV and Zika activities of ribavirin C-nucleosides analogues.,  68  [PMID:35661850] [10.1016/j.bmc.2022.116858]

Source